» Articles » PMID: 6795637

Restricted Reassociation of Heavy and Light Chains from Hapten-specific Monoclonal Antibodies

Overview
Specialty Science
Date 1981 Sep 1
PMID 6795637
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Six murine monoclonal antifluorescyl antibody clones encompassing a defined range of affinities and containing kappa light chains with IgG1 or IgG2 heavy chains were examined. As the fluorescence of the ligand is quenched greater than 90% when fluorescein is bound by antifluorescyl antibodies, fluorescence quenching was assayed to monitor polypeptide reconstitution and active site formation on mixing of resolved heavy (H) and light (L) chains. Of 36 possible experimental combinations of H- and L-chain reaction mixtures, only homologous H and L chains (derived from the same parental immunoglobulin molecule) bound fluorescein. Results from fluorescence polarization studies, conducted independently of fluorescence quenching, confirmed the findings. Competitive inhibition and molecular sieve experiments showed that, despite preferential association of homologous H and L chains, several heterologous H and L chains associated to form intact 7S molecules, although no active site was constituted. Thus, polypeptide recombination and formation of functional antigen binding sites are two processes that immunocytes must regulate during cell differentiation and generation of diversity. A mechanism and underlying the observed preferential reassociation of specific H and L chains and a means of generating affinity maturation, as exhibited by the antifluorescein system, is proposed.

Citing Articles

Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry.

Schaefer W, Volger H, Lorenz S, Imhof-Jung S, Regula J, Klein C MAbs. 2015; 8(1):49-55.

PMID: 26496506 PMC: 4966523. DOI: 10.1080/19420862.2015.1111498.


Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.

Choi B, Gedeon P, Kuan C, Sanchez-Perez L, Archer G, Bigner D J Immunol Methods. 2013; 395(1-2):14-20.

PMID: 23806556 PMC: 3746479. DOI: 10.1016/j.jim.2013.06.003.


Generation of recombinant guinea pig antibody fragments to the human GABAC receptor.

Memic A, Volgina V, Gussin H, Pepperberg D, Kay B J Immunol Methods. 2011; 368(1-2):36-44.

PMID: 21362428 PMC: 3100176. DOI: 10.1016/j.jim.2011.02.010.


Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Anthony R, Nimmerjahn F, Ashline D, Reinhold V, Paulson J, Ravetch J Science. 2008; 320(5874):373-6.

PMID: 18420934 PMC: 2409116. DOI: 10.1126/science.1154315.


Receptor editing: an approach by autoreactive B cells to escape tolerance.

Gay D, Saunders T, Camper S, Weigert M J Exp Med. 1993; 177(4):999-1008.

PMID: 8459227 PMC: 2190958. DOI: 10.1084/jem.177.4.999.


References
1.
Grey H, Mannik M . Specificity of recombination of H and L chains from human gamma-G-myeloma proteins. J Exp Med. 1965; 122(3):619-32. PMC: 2138072. DOI: 10.1084/jem.122.3.619. View

2.
Eisen H, Siskind G . VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE. Biochemistry. 1964; 3:996-1008. DOI: 10.1021/bi00895a027. View

3.
Sonoda S, SCHLAMOWITZ M . Studies of 125I trace labeling of immunoglobulin G by chloramine-T. Immunochemistry. 1970; 7(11):885-98. DOI: 10.1016/0019-2791(70)90051-0. View

4.
Sher A, Lord E, Cohn M . Reconstitution from subunits of the hapten binding sites and idiotypic determinants of mouse anti-phosphorylcholine myeloma proteins. J Immunol. 1971; 107(5):1226-34. View

5.
Manjula B, Glaudemans C, Mushinski E, Potter M . Subunit interactions in mouse myeloma proteins with anti-galactan activity. Proc Natl Acad Sci U S A. 1976; 73(3):932-6. PMC: 336034. DOI: 10.1073/pnas.73.3.932. View